Cell-cell junctions: structure and regulation in physiology and pathology MS Adil, SP Narayanan, PR Somanath Tissue Barriers, 2020 | 80 | 2020 |
The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis A Alwhaibi, A Verma, MS Adil, PR Somanath Pharmacological research 145, 104270, 2019 | 64 | 2019 |
Targeting Akt-associated microRNAs for cancer therapeutics MS Adil, D Khulood, PR Somanath Biochemical Pharmacology, 2020 | 28 | 2020 |
Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cells S Artham, A Verma, A Alwhaibi, MS Adil, S Manicassamy, DH Munn, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 318 (4 …, 2020 | 23 | 2020 |
PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling A Verma, S Artham, A Alwhaibi, MS Adil, BS Cummings, PR Somanath Biochemical pharmacology 177, 113943, 2020 | 21 | 2020 |
EMPADE study: Evaluation of medical prescriptions and adverse drug events in COPD patients admitted to intensive care unit MS Adil, MA Khan, MN Khan, I Sultan, MA Khan, SA Ali, A Farooqui Journal of Clinical and Diagnostic Research: JCDR 9 (11), FC05, 2015 | 21 | 2015 |
Endothelial permeability assays in vitro MS Adil, PR Somanath Permeability Barrier: Methods and Protocols, 177-191, 2021 | 19 | 2021 |
Causality assessment of adverse drug reaction in Pulmonology Department of a Tertiary Care Hospital A Khan, MS Adil, K Nematullah, S Ihtisham, K Aamer, S Aamir Journal of basic and clinical pharmacy 6 (3), 84, 2015 | 19 | 2015 |
Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis A Alwhaibi, A Verma, S Artham, MS Adil, PR Somanath Biochemical pharmacology 168, 1-13, 2019 | 15 | 2019 |
Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis? MS Adil, SP Narayanan, PR Somanath Drug discoveries & therapeutics 14 (5), 256-258, 2020 | 12 | 2020 |
Vascular permeability assays in vivo MS Adil, PR Somanath Permeability Barrier: Methods and Protocols, 165-175, 2021 | 9 | 2021 |
A questionnaire study of food–drug interactions to assess knowledge of people from diverse backgrounds SA Sajid, R Sultana, M Masaratunnisa, S Naaz, MS Adil Asian J. Med. Health 5, 1-9, 2017 | 8 | 2017 |
Convalescent plasma appears efficacious and safe in COVID-19 D Khulood, MS Adil, R Sultana, Nimra Therapeutic Advances in Infectious Disease 7, 2049936120957931, 2020 | 7 | 2020 |
PRIME study: Prescription review to impede medication errors MS Adil, R Sultana, D Khulood International Journal of Risk & Safety in Medicine 31 (2), 67-79, 2020 | 7 | 2020 |
Anti-Tuberculosis Drug-Induced Hepatitis–A Case Report K Amer, SA Aamir, K Nematullah, S Ihtisham, M Maazuddin Indian Journal of Pharmacy Practice 6 (2), 2013 | 7 | 2013 |
Bioinformatics analyses reveal cell-barrier junction modulations in lung epithelial cells on SARS-CoV-2 infection MS Adil, D Khulood, SP Narayanan, PR Somanath Tissue Barriers 10 (3), 2000300, 2022 | 6 | 2022 |
Akt‐independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS‐CoV2 infection MS Adil, A Verma, M Rudraraju, SP Narayanan, PR Somanath Journal of cellular physiology 236 (9), 6597-6606, 2021 | 6 | 2021 |
Cisatracurium attenuates LPS-induced modulation of MMP3 and junctional protein expression in human microvascular endothelial cells RW Kadry, MS Adil, AS Newsome, PR Somanath Bioscience trends 15 (1), 50-54, 2021 | 6 | 2021 |
Distinct effects of pharmacological inhibition of stromelysin1 on endothelial‐to‐mesenchymal transition and myofibroblast differentiation A Alharthi, A Verma, H Sabbineni, MS Adil, PR Somanath Journal of Cellular Physiology, 2020 | 6 | 2020 |
Drug dosing in obese patients: a dilemma A Kaul, MS Adil Int J Adv Pharm 3 (6), 59-65, 2014 | 6 | 2014 |